Vanda Pharmaceuticals Inc. Uncategorized Contracts & Agreements
49 Contracts & Agreements
- Manufacturing Agreement, dated May 6, 2016, by and between Patheon Pharmaceuticals Inc. and the registrant (relating to Fanapt (Filed With SEC on February 24, 2022)
- Manufacturing Agreement, dated January 24, 2014, by and between Patheon Pharmaceuticals Inc. and the registrant (relating to HETLIOZ (Filed With SEC on February 24, 2022)
- Description of Securities of the registrant (Filed With SEC on February 24, 2022)
- Amendment to Rights Agreement, dated June 1, 2018, between the Company and American Stock Transfer and Trust Company, as Rights Agent (Filed With SEC on June 1, 2018)
- Manufacturing Agreement May 6, 2016 Table of Contents (Filed With SEC on July 28, 2016)
- AGREEMENT (Filed With SEC on February 4, 2016)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 13, 2015)
- CONFIDENTIAL TREATMENT REQUESTED AMENDMENT NO. 3 TO SUBLICENSE AGREEMENT (Filed With SEC on March 13, 2015)
- CONFIDENTIAL TREATMENT REQUESTED AMENDMENT NO. 2 TO SUBLICENSE AGREEMENT (Filed With SEC on March 13, 2015)
- CONFIDENTIAL TREATMENT REQUESTED AMENDMENT NO. 1 TO SUBLICENSE AGREEMENT (Filed With SEC on March 13, 2015)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 13, 2015)
- CONFIDENTIAL TREATMENT REQUESTED Manufacturing Agreement January 24, 2014 CONFIDENTIAL TREATMENT REQUESTED Table of Contents (Filed With SEC on May 8, 2014)
- VANDA PHARMACEUTICALS INC. December 2, 2013 (Filed With SEC on February 25, 2014)
- VANDA PHARMACEUTICALS INC. September 12, 2012 (Filed With SEC on November 8, 2012)
- TAX INDEMNITY AGREEMENT (Filed With SEC on March 10, 2011)
- Vanda Pharmaceuticals Inc. (Filed With SEC on March 10, 2011)
- Vanda Pharmaceuticals Inc. (Filed With SEC on March 10, 2011)
- VandaPharmaceuticals Inc. EmploymentAgreement (Filed With SEC on March 10, 2011)
- The election of two directors to serve as Class I directors until the 2013 Annual Meeting of Stockholders (Filed With SEC on June 7, 2010)
- AMENDED AND RESTATED (Filed With SEC on March 15, 2010)
- AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on December 22, 2009)
- Financial Statements (Unaudited) (Filed With SEC on August 10, 2009)
- Financial Statements (Unaudited) (Filed With SEC on August 10, 2009)
- Financial Statements (Unaudited) (Filed With SEC on August 10, 2009)
- Financial Statements (Unaudited) (Filed With SEC on August 10, 2009)
- delays in the completion of our clinical trials (Filed With SEC on March 13, 2009)
- delays in the completion of our clinical trials (Filed With SEC on March 13, 2009)
- delays in the completion of our clinical trials (Filed With SEC on March 13, 2009)
- delays in the completion of our clinical trials (Filed With SEC on March 13, 2009)
- delays in the completion of our clinical trials (Filed With SEC on March 13, 2009)
- delays in the completion of our clinical trials (Filed With SEC on March 13, 2009)
- delays in the completion of our clinical trials (Filed With SEC on March 13, 2009)
- delays in the completion of our clinical trials (Filed With SEC on March 13, 2009)
- delays in the completion of our clinical trials (Filed With SEC on March 13, 2009)
- delays in the completion of our clinical trials (Filed With SEC on March 13, 2009)
- VANDA PHARMACEUTICALS INC. (Filed With SEC on September 25, 2008)
- delays in the completion of our clinical trials (Filed With SEC on March 13, 2008)
- FINANCIAL STATEMENTS (UNAUDITED) (Filed With SEC on November 8, 2007)
- FINANCIAL STATEMENTS (UNAUDITED) (Filed With SEC on November 8, 2007)
- a failure of our product candidates to be demonstrably safe and effective (Filed With SEC on March 16, 2007)
